The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

The pause has raised concerns among health officials and state leaders, as the vague wording leaves billions in Medicaid ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, director of pharmacy at Minnesota Oncology, discusses how the prospect of patient ...

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

Prolonged immigration detention is significantly associated with worsened self-rated health, along with high rates of ...

The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...

Jeffrey V. Matous, MD, discusses how telehealth and remote monitoring can enhance the safe administration of bispecific ...

Jeffrey V. Matous, MD, discusses how primary barriers to the widespread use of bispecific antibody therapies in community ...